Transfer factor as an approach to the treatment of immune deficiency disease.

Abstract

Use of transfer factor in the treatment of chronic mucocutaneous candidiasis is discussed. The clinical experience in treating 2 patients with different clinical expressions of the syndrome and their different responses to treatment with repeated injections of transfer factor given in conjunction with amphotericin-B are reported. Results indicate that this form of therapy is a safe and effective way of restoring cell-mediated immunity to Candida and successfully treating some patients with chronic mucocutaneous candidiasis.

• Authors: M L Schulkind, E M Ayoub
• Journal: Birth defects original article series (Birth Defects Orig Artic Ser) Vol. 11 Issue 1 Pg. 436-40 ( 1975) ISSN: 0547-6844 [Print] United States
• PMID: 1096988 (Publication Type: Journal Article)

Chemical References

• Transfer Factor
• Tritium
• Amphotericin B
• Thymidine

Topics

• Amphotericin B (therapeutic use)
• Candida albicans (immunology)
• Candidiasis, Cutaneous (etiology, immunology, therapy)
• Candidiasis, Oral (etiology)
• Child
• Female
• Humans
• Hypoparathyroidism (etiology)
• Immunity, Cellular
• Immunologic Deficiency Syndromes (complications, therapy)
• Lymphocyte Activation
• Paronychia (etiology)
• Skin Tests
• Thymidine (metabolism)
• Transfer Factor (therapeutic use)
• Tritium
• Vitiligo (etiology)